220 related articles for article (PubMed ID: 20691264)
1. Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models.
Willis S; Stoll J; Sweetman L; Borges K
Neurobiol Dis; 2010 Dec; 40(3):565-72. PubMed ID: 20691264
[TBL] [Abstract][Full Text] [Related]
2. Triheptanoin partially restores levels of tricarboxylic acid cycle intermediates in the mouse pilocarpine model of epilepsy.
Hadera MG; Smeland OB; McDonald TS; Tan KN; Sonnewald U; Borges K
J Neurochem; 2014 Apr; 129(1):107-19. PubMed ID: 24236946
[TBL] [Abstract][Full Text] [Related]
3. Triheptanoin reduces seizure susceptibility in a syndrome-specific mouse model of generalized epilepsy.
Kim TH; Borges K; Petrou S; Reid CA
Epilepsy Res; 2013 Jan; 103(1):101-5. PubMed ID: 23196212
[TBL] [Abstract][Full Text] [Related]
4. Triheptanoin--a medium chain triglyceride with odd chain fatty acids: a new anaplerotic anticonvulsant treatment?
Borges K; Sonnewald U
Epilepsy Res; 2012 Jul; 100(3):239-44. PubMed ID: 21855298
[TBL] [Abstract][Full Text] [Related]
5. Triheptanoin in acute mouse seizure models.
Thomas NK; Willis S; Sweetman L; Borges K
Epilepsy Res; 2012 May; 99(3):312-7. PubMed ID: 22260920
[TBL] [Abstract][Full Text] [Related]
6. Triheptanoin protects against status epilepticus-induced hippocampal mitochondrial dysfunctions, oxidative stress and neuronal degeneration.
Tan KN; Simmons D; Carrasco-Pozo C; Borges K
J Neurochem; 2018 Feb; 144(4):431-442. PubMed ID: 29222946
[TBL] [Abstract][Full Text] [Related]
7. Alterations of hippocampal glucose metabolism by even versus uneven medium chain triglycerides.
McDonald TS; Tan KN; Hodson MP; Borges K
J Cereb Blood Flow Metab; 2014 Jan; 34(1):153-60. PubMed ID: 24169853
[TBL] [Abstract][Full Text] [Related]
8. Reduced severity of ischemic stroke and improvement of mitochondrial function after dietary treatment with the anaplerotic substance triheptanoin.
Schwarzkopf TM; Koch K; Klein J
Neuroscience; 2015 Aug; 300():201-9. PubMed ID: 25982559
[TBL] [Abstract][Full Text] [Related]
9. Triheptanoin alters [U-
McDonald T; Hodson MP; Bederman I; Puchowicz M; Borges K
J Cereb Blood Flow Metab; 2020 Mar; 40(3):678-691. PubMed ID: 30890077
[TBL] [Abstract][Full Text] [Related]
10. Cardiac tissue citric acid cycle intermediates in exercised very long-chain acyl-CoA dehydrogenase-deficient mice fed triheptanoin or medium-chain triglyceride.
Gaston G; Gangoiti JA; Winn S; Chan B; Barshop BA; Harding CO; Gillingham MB
J Inherit Metab Dis; 2020 Nov; 43(6):1232-1242. PubMed ID: 33448436
[TBL] [Abstract][Full Text] [Related]
11. Modification of Astrocyte Metabolism as an Approach to the Treatment of Epilepsy: Triheptanoin and Acetyl-L-Carnitine.
Hadera MG; McDonald T; Smeland OB; Meisingset TW; Eloqayli H; Jaradat S; Borges K; Sonnewald U
Neurochem Res; 2016 Feb; 41(1-2):86-95. PubMed ID: 26433381
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of add-on oral triheptanoin treatment for children with medically refractory epilepsy.
Calvert S; Barwick K; Par M; Ni Tan K; Borges K
Eur J Paediatr Neurol; 2018 Nov; 22(6):1074-1080. PubMed ID: 30126760
[TBL] [Abstract][Full Text] [Related]
13. Alternative Fuels in Epilepsy and Amyotrophic Lateral Sclerosis.
Tefera TW; Tan KN; McDonald TS; Borges K
Neurochem Res; 2017 Jun; 42(6):1610-1620. PubMed ID: 27868154
[TBL] [Abstract][Full Text] [Related]
14. Ketogenic and anaplerotic dietary modifications ameliorate seizure activity in Drosophila models of mitochondrial encephalomyopathy and glycolytic enzymopathy.
Fogle KJ; Smith AR; Satterfield SL; Gutierrez AC; Hertzler JI; McCardell CS; Shon JH; Barile ZJ; Novak MO; Palladino MJ
Mol Genet Metab; 2019 Apr; 126(4):439-447. PubMed ID: 30683556
[TBL] [Abstract][Full Text] [Related]
15. Fructose 1,6-bisphosphate is anticonvulsant and improves oxidative glucose metabolism within the hippocampus and liver in the chronic pilocarpine mouse epilepsy model.
McDonald TS; Neal ES; Borges K
Epilepsy Behav; 2021 Sep; 122():108223. PubMed ID: 34388666
[TBL] [Abstract][Full Text] [Related]
16. Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats.
Kinman RP; Kasumov T; Jobbins KA; Thomas KR; Adams JE; Brunengraber LN; Kutz G; Brewer WU; Roe CR; Brunengraber H
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E860-6. PubMed ID: 16705058
[TBL] [Abstract][Full Text] [Related]
17. Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats. II. Effects on lipolysis, glucose production, and liver acyl-CoA profile.
Gu L; Zhang GF; Kombu RS; Allen F; Kutz G; Brewer WU; Roe CR; Brunengraber H
Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E362-71. PubMed ID: 19903863
[TBL] [Abstract][Full Text] [Related]
18. A novel anticonvulsant mechanism via inhibition of complement receptor C5ar1 in murine epilepsy models.
Benson MJ; Thomas NK; Talwar S; Hodson MP; Lynch JW; Woodruff TM; Borges K
Neurobiol Dis; 2015 Apr; 76():87-97. PubMed ID: 25681535
[TBL] [Abstract][Full Text] [Related]
19. Triheptanoin: long-term effects in the very long-chain acyl-CoA dehydrogenase-deficient mouse.
Tucci S; Floegel U; Beermann F; Behringer S; Spiekerkoetter U
J Lipid Res; 2017 Jan; 58(1):196-207. PubMed ID: 27884962
[TBL] [Abstract][Full Text] [Related]
20. Triheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral Sclerosis.
Tefera TW; Wong Y; Barkl-Luke ME; Ngo ST; Thomas NK; McDonald TS; Borges K
PLoS One; 2016; 11(8):e0161816. PubMed ID: 27564703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
